Φορτώνει......
The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | HPB (Oxford) |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/ https://ncbi.nlm.nih.gov/pubmed/27154804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|